Investigating Angiogenesis-Related Biomarkers in Osteoarthritis Patients Through Transcriptomic Profiling
Yang Zheng,Miaojia Fang,Shriya Sanan,Xi-Hui Meng,Jie-Feng Huang,Yu Qian
DOI: https://doi.org/10.2147/jir.s493889
IF: 4.5
2024-12-09
Journal of Inflammation Research
Abstract:Yang Zheng, 1 Miaojia Fang, 2 Shriya Sanan, 1 Xi-Hui Meng, 1 Jie-Feng Huang, 1 Yu Qian 1 1 Zhejiang Provincial Hospital of Traditional Chinese Medicine, Hangzhou, People's Republic of China; 2 Institute of Forensic Science, Yuhang Public Security Department, Hangzhou, People's Republic of China Correspondence: Yu Qian, Zhejiang Provincial Hospital of Traditional Chinese Medicine, 54 Youdian Road, Shangcheng District, Hangzhou, 310006, People's Republic of China, Tel +86-571-87068001, Fax +86-571-87034117, Email Background: Osteoarthritis (OA) is a common age-related joint disease characterized by joint destruction and impaired quality of life. Angiogenesis plays a vital role in OA progression. This study aimed to identify key angiogenesis-related genes (ARGs) in OA using transcriptomic and machine learning methods. Methods: The GSE55235 dataset (10 OA and 10 healthy synovial tissue samples) was analyzed for differentially expressed genes (DEGs), integrated with weighted gene co-expression network analysis (WGCNA), and ARGs to identify differentially expressed ARGs (DE-ARGs). Candidate genes were identified through three machine learning algorithms and evaluated using ROC curve analysis. Gene set enrichment analysis (GSEA), immune cell infiltration analysis, and therapeutic agent prediction were performed. Synovial samples from 5 OA patients and 5 matched controls were collected for RT-qPCR validation of biomarkers. Results: From 1552 DEGs, 11 DE-ARGs were identified, and six candidate genes were selected using machine learning. Four genes—COL3A1, OLR1, STC1, and KCNJ8—showed AUC > 0.8 in both GSE55235 and GSE1919, indicating strong diagnostic value. GSEA linked biomarkers to the "lysosome" pathway, and eosinophils and Th2 cells were significantly associated with biomarkers. Potential therapeutic agents included bisphenol A, tetrachlorodibenzo-p-dioxin, and valproic acid. Clinical validation confirmed that COL3A1, OLR1, and STC1 expression levels were consistent with database findings. Conclusion: The study identified COL3A1, OLR1, STC1, and KCNJ8 as key angiogenesis-related biomarkers in osteoarthritis, which could serve as potential diagnostic tools and therapeutic targets. The research underscores the importance of angiogenesis in osteoarthritis progression and suggests that targeting angiogenesis-related pathways may offer new treatment strategies. Keywords: osteoarthritis, angiogenesis, biomarker, immune infiltration, regulatory network Osteoarthritis (OA) (ICD-10: M19) is a common degenerative joint disease marked by the progressive breakdown of joint cartilage, osteophyte formation, subchondral bone sclerosis, and synovial inflammation. 1 It results from a combination of mechanical stress, inflammation, and biochemical factors, causing pain, stiffness, and reduced joint mobility. In individuals aged 40 to 60, the prevalence of OA is approximately 10–17% and around 50%, respectively. Among those aged 75 and older, the prevalence rises significantly to about 80%. 2 Factors like gender, geography, and physical labor intensity influence its prevalence. In China, women are 1–2 times more susceptible than men, and colder, humid regions and occupations involving heavy labor or prolonged standing show higher OA rates. 3,4 Current OA management focuses on symptom relief through nonsteroidal anti-inflammatory drugs (NSAIDs), intra-articular hyaluronic acid injections, and physical therapy to reduce pain and improve function. 2–4 However, these treatments cannot stop disease progression or repair damaged cartilage. Recent research seeks new biomarkers and therapeutic targets to better understand OA's underlying mechanisms, aiming to develop more effective interventions that delay or prevent joint degeneration. 3–5 Emerging research identifies angiogenesis as a critical pathological mechanism in OA progression. Unlike healthy avascular cartilage, OA cartilage experiences abnormal vascularization driven by increased osteoclast activity, which creates channels between subchondral bone and cartilage. 5 This process facilitates the influx of sensory nerves, exacerbating joint pain and accelerating cartilage degradation. Targeting angiogenesis could offer a promising therapeutic strategy for OA. However, significant gaps persist in identifying angiogenesis-related biomarkers to improve diagnosis and treatment. While prior studies have emphasized symptom management and structural changes, the molecular mechanisms underlying vascularization remain underexplored. 4,5 This study aims to bridge existing gaps by identifying angiogenesis-related biomarkers in OA through transcriptomic ana -Abstract Truncated-
immunology